Aberrant DNA hypermethylation patterns lead to transcriptional silencing of tumor suppressor genes in UVB-exposed skin and UVB-induced skin tumors of mice.
暂无分享,去创建一个
[1] B. Korn,et al. Aging and Chronic Sun Exposure Cause Distinct Epigenetic Changes in Human Skin , 2010, PLoS genetics.
[2] S. Katiyar,et al. Inhibition of UVB-induced skin tumor development by drinking green tea polyphenols is mediated through DNA repair and subsequent inhibition of inflammation. , 2009, The Journal of investigative dermatology.
[3] J. Arbiser,et al. The reactive oxygen‐driven tumor: relevance to melanoma , 2008, Pigment cell & melanoma research.
[4] L. Hesson,et al. RASSF6 is a novel member of the RASSF family of tumor suppressors , 2007, Oncogene.
[5] C. Elmets,et al. Interleukin-12 deficiency is permissive for angiogenesis in UV radiation-induced skin tumors. , 2007, Cancer research.
[6] S. Katiyar,et al. Dietary grape seed proanthocyanidins inhibit UVB-induced oxidative stress and activation of mitogen-activated protein kinases and nuclear factor-κB signaling in in vivo SKH-1 hairless mice , 2007, Molecular Cancer Therapeutics.
[7] J. Minna,et al. Sun exposure related methylation in malignant and non-malignant skin lesions. , 2007, Cancer letters.
[8] K. Hatakeyama,et al. Chronic oral exposure to inorganic arsenate interferes with methylation status of p16INK4a and RASSF1A and induces lung cancer in A/J mice. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[9] S. O’Day,et al. Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] C. Elmets,et al. Orally administered green tea polyphenols prevent ultraviolet radiation-induced skin cancer in mice through activation of cytotoxic T cells and inhibition of angiogenesis in tumors. , 2005, The Journal of nutrition.
[11] S. Baylin,et al. DNA methylation and gene silencing in cancer , 2005, Nature Clinical Practice Oncology.
[12] K. Robertson. DNA methylation and human disease , 2005, Nature Reviews Genetics.
[13] Li Yu,et al. [DNA methylation and cancer]. , 2005, Zhonghua nei ke za zhi.
[14] H. Ananthaswamy,et al. Cellular and molecular events leading to the development of skin cancer. , 2005, Mutation research.
[15] M. You,et al. Tumor susceptibility of Rassf1a knockout mice. , 2005, Cancer research.
[16] J. Arbiser,et al. Involvement of p53 and p16 tumor suppressor genes in recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma. , 2004, The Journal of investigative dermatology.
[17] D. Morton,et al. Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients , 2004, Oncogene.
[18] Yasuhiro Matsumura,et al. Toxic effects of ultraviolet radiation on the skin. , 2004, Toxicology and applied pharmacology.
[19] J. Herman,et al. Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.
[20] S. Katiyar,et al. Exceptionally high protection of photocarcinogenesis by topical application of (--)-epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model: relationship to inhibition of UVB-induced global DNA hypomethylation. , 2003, Neoplasia.
[21] J. Herman,et al. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors , 2003, Nature Genetics.
[22] M. Ehrlich,et al. DNA methylation in cancer: too much, but also too little , 2002, Oncogene.
[23] Peter A. Jones,et al. The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.
[24] A. Wolffe,et al. Precipitous Release of Methyl-CpG Binding Protein 2 and Histone Deacetylase 1 from the Methylated Human Multidrug Resistance Gene (MDR1) on Activation , 2002, Molecular and Cellular Biology.
[25] M. Loda,et al. Obligate Roles for p16Ink4a and p19Arf-p53 in the Suppression of Murine Pancreatic Neoplasia , 2002, Molecular and Cellular Biology.
[26] P. Wade. Methyl CpG‐binding proteins and transcriptional repression * , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.
[27] S. Baylin,et al. Dnmt3a and Dnmt3b Are Transcriptional Repressors That Exhibit Unique Localization Properties to Heterochromatin* , 2001, The Journal of Biological Chemistry.
[28] T. Kouzarides,et al. Dnmt3a binds deacetylases and is recruited by a sequence‐specific repressor to silence transcription , 2001, The EMBO journal.
[29] N. Ahuja,et al. Accelerated age-related CpG island methylation in ulcerative colitis. , 2001, Cancer research.
[30] A. Wolffe,et al. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[31] J. Herman,et al. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. , 2000, Trends in genetics : TIG.
[32] A. Bird,et al. Active Repression of Methylated Genes by the Chromosomal Protein MBD1 , 2000, Molecular and Cellular Biology.
[33] A. Bird,et al. Methylation-Induced Repression— Belts, Braces, and Chromatin , 1999, Cell.
[34] D. Haber,et al. DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.
[35] E. Li,et al. Cloning, expression and chromosome locations of the human DNMT3 gene family. , 1999, Gene.
[36] Peter A. Jones,et al. Cancer-epigenetics comes of age , 1999, Nature Genetics.
[37] P. Jones,et al. The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines. , 1998, Cancer research.
[38] G. Pfeifer,et al. Sunlight induces pyrimidine dimers preferentially at 5-methylcytosine bases. , 1997, Cancer research.
[39] S. Cross,et al. A component of the transcriptional represser MeCP1 shares a motif with DNA methyltransferase and HRX proteins , 1997, Nature Genetics.
[40] P. Jones,et al. Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. , 1997, Carcinogenesis.
[41] R. Tarone,et al. Frequent clones of p53-mutated keratinocytes in normal human skin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[42] C. Elmets,et al. Photocarcinogenesis: Mechanisms, Models and Human Health Implications: Introduction , 1996 .
[43] J. Goodman,et al. Alterations in DNA methylation may play a variety of roles in carcinogenesis , 1995, Cell.
[44] Adrian Bird,et al. DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein , 1991, Cell.
[45] A. Bird. CpG-rich islands and the function of DNA methylation , 1986, Nature.
[46] C. Rödel,et al. What is the role of radiotherapy in bladder-preserving cancer therapy? , 2005, Nature Clinical Practice Oncology.
[47] M. You,et al. Tumor Susceptibility of Rassf 1 a Knockout Mice , 2004 .
[48] R. Watson,et al. Altered DNA methylation: a secondary mechanism involved in carcinogenesis. , 2002, Annual review of pharmacology and toxicology.
[49] C. Elmets,et al. Photocarcinogenesis: mechanisms, models and human health implications. , 1996, Photochemistry and photobiology.
[50] R. Jaenisch,et al. The role of DNA methylation in cancer genetic and epigenetics. , 1996, Annual review of genetics.
[51] Peter W. Laird,et al. THE ROLE OF DNA METHYLATION IN CANCER GENETICS AND EPIGENETICS , 1996 .